Innovations in Healthcare: A Discussion with Dr. Craig Joseph at HIMSS 2024

 

Innovations in healthcare were easy to spot at the recent HIMSS 2024 conference. Healthcare Rethink’s Brian Urban caught up with one of those innovators for a live discussion at HIMSS 2024. podcast, Their conversation opens a window and dialogue into the cutting-edge trends reshaping healthcare technology today.

This episode features Dr. Craig Joseph, the Chief Medical Officer at Nordic Global Consulting and a seasoned author, discussing his transition from pediatric practice to healthcare technology. Specifically, they explore the evolution of digital transformation and innovations in healthcare, a journey from simple electronic record implementations to sophisticated, user-friendly systems that significantly enhance care delivery.

Dr. Joseph shared insights into integrating technology in healthcare, emphasizing the importance of making complex systems accessible and efficient for healthcare professionals and patients. The dialogue also touched on challenges like cybersecurity in the healthcare sector and the critical role of continuous innovation and adaptation in effectively facing these threats.

Recent Episodes

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…